Upgrades/Downgrades
Updated: 31-Aug-26 09:45 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| XP | XP | Itau BBA | Market Perform » Outperform | $22 | |
| Titan Machinery | TITN | Robert W. Baird | Neutral » Outperform | $29 | |
| STAG Industrial | STAG | Robert W. Baird | Neutral » Outperform | $42 | |
| Kaiser Alum | KALU | UBS | Neutral » Buy | $184 | |
| Deere | DE | Robert W. Baird | Neutral » Outperform | $800 | |
| CNH Industrial | CNH | Robert W. Baird | Neutral » Outperform | $15 | |
| Chagee | CHA | Macquarie | Neutral » Outperform | $15.70 | |
| AGCO Corp | AGCO | Robert W. Baird | Neutral » Outperform | $150 | |
| Abercrombie & Fitch | ANF | Argus | Hold » Buy | $162 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Tenax Therapeutics | TENX | Guggenheim | Buy » Neutral | ||
| Sempra Energy | SRE | Mizuho | Outperform » Neutral | $84 | |
| PG&E | PCG | Mizuho | Outperform » Neutral | $16 | |
| PG&E | PCG | BMO Capital Markets | Outperform » Market Perform | $21 | |
| PG&E | PCG | Wells Fargo | Overweight » Equal Weight | $24 | |
| Miniso Group | MNSO | Citigroup | Buy » Neutral | $11.30 | |
| Miniso Group | MNSO | HSBC Securities | Buy » Hold | $10.80 | |
| HDFC Bank | HDB | HSBC Securities | Buy » Hold | ||
| Edison | EIX | Mizuho | Outperform » Neutral | $70 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| River City Bank | RCBC | Raymond James | Outperform | $56 | |
| Ticketplus Ltd. | TP | Roth Capital | Buy | $14 | |
| Smith & Nephew | SNN | BTIG Research | Neutral | ||
| Scribe Therapeutics | SCTX | H.C. Wainwright | Buy | $60 | |
| River City Bank | RCBC | DA Davidson | Neutral | $55 | |
| River City Bank | RCBC | Stephens | Equal-Weight | $54 | |
| Red Cat Holdings | RCAT | Evercore ISI | Outperform | $15 | |
| Quantum BioPharma Ltd | QNTM | Rodman & Renshaw | Buy | $8 | |
| Lumentum | LITE | Evercore ISI | Outperform | $1100 | |
| Deep Fission | FISN | Maxim Group | Buy | $17 | |
| Braveheart Bio | BRVE | TD Cowen | Buy | ||
| Braveheart Bio | BRVE | Stifel | Buy | $45 | |
| Braveheart Bio | BRVE | Jefferies | Buy | $48 | |
| Braveheart Bio | BRVE | Goldman | Buy | $48 | |
| Braveheart Bio | BRVE | Cantor Fitzgerald | Overweight | $40 | |
| Babcock & Wilcox Enterprises | BW | Needham | Buy | $20 | |
| Attovia Therapeutics | ATTO | RBC Capital Mkts | Outperform | $45 | |
| Attovia Therapeutics | ATTO | Morgan Stanley | Overweight | $39 | |
| Attovia Therapeutics | ATTO | Citigroup | Buy | $30 | |
| Attovia Therapeutics | ATTO | Leerink Partners | Outperform | $52 | |
| AirJoule Technologies Corp. | AIRJ | Needham | Hold | ||
| Gorilla Technology Group | GRRR | B. Riley Securities | Buy | $25 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| MongoDB | MDB | Monness Crespi & Hardt | Buy | $415 » $460 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |